Shingrix Herpes Zoster Vaccine from Canada
Shingrix is a recombinant glycoprotein E antigen with AS01B adjuvant for shingles prevention in adults over 50. Contains antigens in measured doses, classified under HTS 3004.90.10.00.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Pharmaceuticals: patented pharma articles — 100% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Specify adjuvant composition to avoid 3004.90.90
• Comply with geriatric vaccination program import protocols
• Monitor for 2-year shelf life expiration during transit